Baxter International Inc. ($BAX) Stock Forecast: Down 5.4% Today

What is Baxter International Inc.?

Baxter International Inc. (NYSE: BAX) is a global healthcare company specializing in treatments for hemophilia, kidney disease, immune disorders, and various chronic and acute medical conditions. The company operates in two segments: Hospital Products and Renal.

Why is Baxter International Inc. going down?

BAX stock is down 5.4% on Oct 31, 2025 15:40

• Today's downward trend in Baxter International Inc. (BAX) stock may be linked to the following factors:
• A pending securities fraud class action lawsuit by The Gross Law Firm has caused apprehension among investors, resulting in a decrease in confidence and a sell-off of shares.
• Baxter has revised its annual outlook and lowered its 2025 guidance on multiple occasions, which might have negatively impacted investor sentiment, with the stock hitting a 52-week low after the latest adjustment in guidance.
• Despite Baxter's Q3 earnings surpassing expectations, the stock dropped due to a sales shortfall and a downward revision in the 2025 EPS forecast, suggesting potential challenges in revenue generation ahead.
• Ongoing investigations and shareholder alerts by legal firms like Faruqi & Faruqi, LLP and Bernstein Liebhard LLP have contributed to the overall uncertainty surrounding the company, potentially influencing the bearish market movement.

BAX Price Chart

BAX Technical Analysis

BAX News

Baxter International, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX - Baxter Intl ( NYSE:BAX )

NEW YORK, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. ( NYSE:BAX ) . Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead ...

https://www.benzinga.com/pressreleases/25/10/g48545828/baxter-international-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-

Baxter Trims Annual Outlook Again, Stock Hits 52-Week - Baxter Intl ( NYSE:BAX )

Baxter International Inc. ( NYSE:BAX ) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance. Baxter reported a third-quarter adjusted EPS of 69 cents, surpassing the management guidance of 58-62 cents and the Wall Street estimate of 60 cents.

https://www.benzinga.com/markets/earnings/25/10/48540569/baxter-trims-annual-outlook-again-stock-hits-52-week

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Baxter Intl ( NYSE:BAX )

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options

https://www.benzinga.com/pressreleases/25/10/g48532936/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-baxter-internat

BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down

Baxter's Q3 earnings top forecasts, but sales lag and 2025 EPS guidance slips. shares fall despite strength in Pharma and Advanced Surgery.

https://www.zacks.com/stock/news/2781672/bax-stock-falls-following-q3-earnings-beat-sales-miss-25-eps-view-down

BAXTER INTERNATIONAL INC. ( NYSE: BAX ) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline - Baxter Intl ( NYSE:BAX )

NEW YORK, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Baxter International Inc. ( "Baxter" or the "Company" ) ( NYSE:BAX ) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced ...

https://www.benzinga.com/pressreleases/25/10/g48526169/baxter-international-inc-nyse-bax-shareholder-alert-bernstein-liebhard-llp-reminds-baxter-internat

Trending Today

Baxter International Inc. Price History

07.10.2024 - BAX Stock was up 0.3%

• Baxter's stock experienced a strong bullish movement today due to positive expectations regarding its third-quarter earnings.
• The surge in Baxter's stock can be attributed to the anticipated favorable Q3 earnings driven by strong product demand, positive pricing impact, and recent new product introductions.
• Despite possible cost increases from supply chain challenges, investors remain positive about Baxter's future performance, contributing to the upward movement in the stock price.
• Investors are keenly interested in analyzing key metrics and the company's overall performance in addition to traditional revenue and EPS estimates to gain a comprehensive view of Baxter's financial well-being.

08.10.2024 - BAX Stock was down 5.0%

• Despite exceeding third-quarter expectations in terms of earnings and sales, Baxter faced a stock decline due to reduced gross and operating margins.
• The aftermath of Hurricane Helene is predicted to have a financial impact on Baxter in the short term, potentially causing unease among investors and contributing to the downward movement.
• While a strong demand and favorable pricing environment were projected to boost Baxter's Q3 earnings, complications in the supply chain likely led to increased expenses, influencing the stock's drop.
• Investors, looking beyond revenue and EPS, may have lingering concerns about Baxter's future performance despite surpassing earnings estimates, which has added to the overall bearish sentiment in the market.

31.06.2025 - BAX Stock was down 21.0%

• Baxter International Inc. (BAX) experienced a significant bearish movement following its Q2 earnings report, where it missed both earnings and sales expectations.
• The company also revised its full-year EPS outlook downwards, leading to a lack of confidence among investors and a sharp decline in the stock price.
• The weaker gross margin reported by Baxter further added to the negative sentiment, causing shares to slide nearly 9% pre-market.
• The disappointing earnings results and lowered guidance suggest that Baxter may be facing challenges in its core segments, impacting investor perception and leading to the bearish market movement.

31.06.2025 - BAX Stock was down 19.7%

• The bearish movement in Baxter's stock today could be attributed to the market's reaction to the upcoming Q2 earnings report.
• Investors might be concerned about Baxter's ability to meet Wall Street's expectations for key metrics and deliver another solid quarter.
• The uncertainty surrounding the company's core segments' performance and the pressure to achieve modest growth could have contributed to the negative sentiment in the market.
• Traders might be reacting to the possibility of margin gains stabilizing after a recent recovery, which could impact Baxter's overall financial outlook and future growth prospects.

08.10.2024 - BAX Stock was down 5.1%

• Baxter surpassed expectations in its third-quarter financial performance, exceeding both earnings and sales forecasts. However, the stock declined as gross and operating margins contracted.
• The company's financial outlook was affected by Hurricane Helene's aftermath, raising concerns about its short-term prospects.
• While higher demand and pricing were anticipated to boost earnings, supply-chain challenges increased costs, influencing the stock's negative movement.
• Investors may have reacted poorly to the mix of positive financial results with margin contraction, contributing to the stock's bearish direction.

30.09.2025 - BAX Stock was down 14.2%

• There was a downward revision in Baxter International Inc.'s 2025 guidance, resulting in a notable decline in its stock value to a 52-week low.
• Despite exceeding expectations in its third-quarter earnings report, the company's reduced sales and EPS projections for 2025 influenced the negative market sentiment.
• Legal inquiries from Faruqi & Faruqi, LLP and a securities fraud class action lawsuit caution from Bernstein Liebhard LLP potentially heightened investor worries and further impacted the stock's performance.
• The stock faced a bearish trend following the mixed reactions to Baxter's Q3 earnings, which included surpassing earnings but missing sales targets, along with a downward adjustment in its 2025 EPS guidance.

30.09.2025 - BAX Stock was down 17.0%

• A looming deadline for a securities fraud class action lawsuit could have caused unease among investors, triggering a selloff of Baxter International Inc. shares.
• Weaknesses in the IV fluid and anesthesia segments, noted in the Q3 preview, may have raised concerns about the company's future revenue and earnings performance.
• Ongoing shareholder litigations and legal investigations might have heightened the negative sentiment surrounding Baxter International Inc., exerting downward pressure on its stock value.
• In sum, the intertwining factors of legal uncertainties, segment vulnerabilities, and shareholder disputes likely contributed to the bearish market movement witnessed in Baxter International Inc. today.

30.09.2025 - BAX Stock was down 14.8%

• Baxter International Inc. (BAX) surpassed Q3 earnings expectations but missed sales targets, prompting a downward revision of their 2025 EPS guidance.
• Despite positive performances in Pharma and Advanced Surgery, concerns arose among investors due to the overall sales miss and reduced EPS outlook, leading to a bearish market movement.
• The presence of an upcoming securities fraud class action lawsuit deadline and investor alerts may have further fueled negative sentiments around the company, impacting the stock price negatively.
• Investors are focusing on Baxter's core segments, notably Advanced Surgery and Drug Compounding, in the next quarter to evaluate the company's growth prospects in light of challenges faced by other product lines like IV fluids and anesthesia.

08.04.2025 - BAX Stock was up 5.3%

• The decline in short interest suggests growing investor confidence in Baxter Intl's future outlook.
• The positive market sentiment might be influenced by recent progress in healthcare, including treatment advancements and successful clinical trials.
• Investors could also be responding favorably to Baxter Intl's financial performance and strategic moves aimed at fostering growth.
• In summary, today's bullish movement in Baxter Intl's stock seems to stem from both reduced short interest and positive industry trends.

20.01.2025 - BAX Stock was up 8.9%

• Baxter's strong bullish movement today can be attributed to the better-than-expected Q4 adjusted EPS results, which exceeded both consensus estimates and the company's own guidance. This positive earnings report indicates that the company is performing well and has a solid financial outlook.
• The optimistic forecast for 2025 sales growth and adjusted EPS further boosted investor confidence in Baxter's future prospects, leading to increased buying interest in the stock.
• Despite the Q1 2025 EPS being projected below analyst estimates, the overall positive sentiment surrounding Baxter's performance and outlook likely overshadowed this minor concern, driving the stock price higher.
• Overall, Baxter's impressive financial results and optimistic guidance have propelled the stock to a bullish trajectory, reflecting investor optimism and confidence in the company's growth potential.

02.04.2025 - BAX Stock was down 5.0%

• Baxter exceeded sales expectations for medical devices in Q1, surpassing both internal projections and analyst forecasts.
• The optimistic guidance for 2025 should have instilled confidence in the company's future growth trajectory.
• Market volatility and unpredictability likely influenced profit-taking or broader concerns, leading to a decline in Baxter's stock value.
• Investor reactions to market conditions may have overshadowed the company-specific positive news, contributing to the stock's downward movement.

31.09.2025 - BAX Stock was down 5.4%

• Today's downward trend in Baxter International Inc. (BAX) stock may be linked to the following factors:
• A pending securities fraud class action lawsuit by The Gross Law Firm has caused apprehension among investors, resulting in a decrease in confidence and a sell-off of shares.
• Baxter has revised its annual outlook and lowered its 2025 guidance on multiple occasions, which might have negatively impacted investor sentiment, with the stock hitting a 52-week low after the latest adjustment in guidance.
• Despite Baxter's Q3 earnings surpassing expectations, the stock dropped due to a sales shortfall and a downward revision in the 2025 EPS forecast, suggesting potential challenges in revenue generation ahead.
• Ongoing investigations and shareholder alerts by legal firms like Faruqi & Faruqi, LLP and Bernstein Liebhard LLP have contributed to the overall uncertainty surrounding the company, potentially influencing the bearish market movement.